A股異動 | 齊翔騰達(002408.SZ)續升超7%創歷史新高 月內累計飆漲32%
格隆匯9月15日丨齊翔騰達(002408.SZ)延續漲勢,大幅拉昇漲超7%,高見18.78元再創歷史新高價,月內已飆漲32%,總市值達370億元。公司10萬噸/年甲乙酮裝置日前檢修完成並恢復生產。東興證券指出,公司作為甲乙酮和順酐行業全球龍頭,國內市佔率高達50%和30%以上,公司出口佔國內出口比例高達70%和50%。甲乙酮行業產業鏈地位高,環保推動順酐和甲乙酮需求空間擴大,公司作為全球龍頭將充分受出口拉動和行業新變化。首予“強烈推薦”投資評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.